Shigeki Ito
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Spine and Intervertebral Disc Pathology
Papers in
- Hematology 48
- Multiple Myeloma Research and Treatments 30
- Platelet Disorders and Treatments 9
- Oncology 27
- Co-authors
- Paul C. Ivancic (11 shared papers)Manohar M. Panjabi (11 shared papers)Adam M. Pearson (5 shared papers)Yoji Ishida (36 shared papers)Kazunori Murai (27 shared papers)Jaw‐Lin Wang (3 shared papers)Jun Takebe (5 shared papers)Bryan W. Cunningham (2 shared papers)
- Journals
- Blood (19 papers)International Journal of Hematology (11 papers)Leukemia Research (6 papers)Spine (5 papers)Health Physics (4 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Shigeki Ito
126 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 134
- Hematology 351
- Pathology and Forensic Medicine 419
- Radiation 169
- Immunology 330
- Hepatology 98
Countries citing papers authored by Shigeki Ito
This map shows the geographic impact of Shigeki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Ito more than expected).
Fields of papers citing papers by Shigeki Ito
This network shows the impact of papers produced by Shigeki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Ito. The network helps show where Shigeki Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Shigeki Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 134 | |
| 2 | 2016 | 105 | |
| 3 | Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. | 1996 | 93 |
| 4 | 2015 | 81 | |
| 5 | 2003 | 70 | |
| 6 | 2007 | 67 | |
| 7 | 2004 | 66 | |
| 8 | 1996 | 64 | |
| 9 | 1999 | 63 | |
| 10 | Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. | 1984 | 60 |
| 11 | 2004 | 52 | |
| 12 | 2006 | 49 | |
| 13 | 2020 | 48 | |
| 14 | 2004 | 43 | |
| 15 | 2006 | 42 | |
| 16 | 2016 | 40 | |
| 17 | 2018 | 38 | |
| 18 | 2017 | 33 | |
| 19 | 2014 | 32 | |
| 20 | 2006 | 30 |
About Shigeki Ito
Shigeki Ito is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), T-cell and Retrovirus Studies (13 papers), Radiation Detection and Scintillator Technologies (12 papers), Medical Imaging Techniques and Applications (12 papers), Spine and Intervertebral Disc Pathology (11 papers), Protein Degradation and Inhibitors (10 papers), Platelet Disorders and Treatments (9 papers) and Vector-Borne Animal Diseases (9 papers). The work is most often cited by research in Hematology (351 citations), Pathology and Forensic Medicine (419 citations), Radiation (169 citations), Immunology (330 citations) and Hepatology (98 citations). Shigeki Ito has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Paul C. Ivancic, Manohar M. Panjabi, Adam M. Pearson, Yoji Ishida, Kazunori Murai, Jaw‐Lin Wang, Jun Takebe, Bryan W. Cunningham, Kanji Ishibashi and Timothy Campbell. Their work appears in journals such as Blood, International Journal of Hematology, Leukemia Research, Spine and Health Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.